HEMŞİNLİ, D. Et Al. 2022. Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.44, no.7 , 595-600.

HEMŞİNLİ, D., TÜMKAYA, L., ERGENE, Ş., KARAKİŞİ, S. O., MERCANTEPE, T., & YILMAZ, A., (2022). Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.44, no.7, 595-600.

HEMŞİNLİ, DOĞUŞ Et Al. "Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.44, no.7, 595-600, 2022

HEMŞİNLİ, DOĞUŞ Et Al. "Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.44, no.7, pp.595-600, 2022

HEMŞİNLİ, D. Et Al. (2022) . "Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.44, no.7, pp.595-600.

@article{article, author={DOĞUŞ HEMŞİNLİ Et Al. }, title={Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury}, journal={CLINICAL AND EXPERIMENTAL HYPERTENSION}, year=2022, pages={595-600} }